Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?

Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?

In late December 2019, a novel coronavirus (SARS-CoV-2 or CoV-19) appeared in Wuhan, China, causing a global pandemic. SARS-CoV-2 causes mild to severe respiratory tract inflammation, often developing into lung fibrosis with thrombosis in pulmonary small vessels and causing even death. COronaVIrus D...

Full description

Bibliographic Details
Main Authors: Francesca Rossi, Chiara Tortora, Maura Argenziano, Alessandra Di Paola, Francesca Punzo
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:International Journal of Molecular Sciences
Subjects:
SARS-CoV-2
cannabinoid receptor type 2
therapeutic strategies
molecular target
immune response
inflammation
Online Access:https://www.mdpi.com/1422-0067/21/11/3809

Similar Items

Similar Items